You are here

Cognetivity Neurosciences Ltd.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
CGN
CSE Index: 
Currency: 

Cognetivity Neurosciences Ltd. is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA) for use in medical and commercial environments. Cognetivity’s ICA uses Artificial Intelligence and machine learning techniques to help detect the earliest signs of impairment by testing the performance of large areas of the brain, potentially allowing early diagnosis of dementia. Cognetivity aims to develop the ICA through planned clinical studies to the market in North America and Europe.

You are here

Cognetivity Neurosciences Ltd. (CGN)

SEDAR Information

Company Info

Address
1980 - 1075 West Georgia Street
Vancouver, BC V6E 3C9
Canada
Phone
604-688-9588
Fax
778-329-9361
Email
info@cognetivity.com
Website
http://www.cognetivity.com
Listing date
Monday, March 19, 2018
Transfer Agent
TSX Trust Company

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
41,477,022
Reserved for Issuance: 
22,923,402

News Releases

Bulletins

15/03/2018

2018-0316 – New Listing – Cognetivity Neurosciences Ltd. (CGN)

Le 15 mars/March 2018

The common shares of Cognetivity Neurosciences Ltd. have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the listing date.

Advertisement

Publicité

Latest CSE News

Upcoming Events

11_18_Cannabis_Invest_UK_Website

Cannabis Invest UK

Monday, November 18, 2019 -
9:00am to 7:00pm
11-20_US_Cannabis_Regulatory_Update_-_Website

U.S. Cannabis Regulatory Update

Wednesday, November 20, 2019 -
3:00pm to 7:00pm